We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Treatment of mastopathy: the last possible risk].
Medizinische Klinik 1981 September 26
52 patients with mastopathia were treated with Mastodynon. The drug was given twice daily in a dose of 30 drops over a period of at least three cycles. 24 out of 52 patients had no more pain at all; in 15 patients pain was decreased to a minimum. Mastodynon showed side effects in only four cases where gastric incompatibility was found. Therapy with Mastodynon is an effective alternative to surgical or hormone treatment.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app